Skip to main content
Erschienen in: Journal of Neuro-Oncology 3/2009

01.07.2009 | Clinical study - patient study

Contribution of the daily melatonin profile to diagnosis of tumors of the pineal region

verfasst von: José Leston, Carmine Mottolese, Jacques Champier, Anne Jouvet, Jocelyne Brun, Marc Sindou, Guy Chazot, Bruno Claustrat, Michelle Fèvre-Montange

Erschienen in: Journal of Neuro-Oncology | Ausgabe 3/2009

Einloggen, um Zugang zu erhalten

Abstract

Tumors of the pineal region (TPR) include different entities: germ cell tumors (GCT), pineal parenchymal tumors (PPT), meningiomas, and glial tumors. Except for GCT, there are no peripheral markers and histopathological diagnosis needs biopsy or surgery. We studied daily melatonin variations in twenty-nine patients with TPR and five with tectal plate glioma (TPG), used as controls, before and/or after surgery. Before surgery, a melatonin nycthemeral rhythm was observed in patients with TPG and TPR (one cyst, three PPT, one papillary tumor of the pineal region, two meningiomas, six gliomas). Melatonin rhythm was dramatically reduced for undifferentiated or invasive tumors. After surgery, the absence of melatonin variation in some cases could be the consequence of pineal damage by surgery. The contribution of determination of melatonin profiles to the diagnosis of TPR remains limited but of interest. The evidence for melatonin deficiency could justify melatonin administration to prevent the postpinealectomy syndrome.
Literatur
2.
Zurück zum Zitat Rosenblum MK (2006) Germ cell tumors. In: Mc Lendon R, Bigner DD, Rosenblum M (eds) Russel & Rubinstein’s pathology of tumors of the nervous system, vol 44, 7th edn. Hodder Arnold, London, pp 551–577 Rosenblum MK (2006) Germ cell tumors. In: Mc Lendon R, Bigner DD, Rosenblum M (eds) Russel & Rubinstein’s pathology of tumors of the nervous system, vol 44, 7th edn. Hodder Arnold, London, pp 551–577
3.
Zurück zum Zitat Arendt J (1978) Melatonin as a tumour marker in a patient with pineal tumour. BMJ 2:635–636 Arendt J (1978) Melatonin as a tumour marker in a patient with pineal tumour. BMJ 2:635–636
4.
Zurück zum Zitat Barber SG, Smith JA, Hughes RC (1978) Melatonin as a tumour marker in a patient with pineal tumour. BMJ 2:328PubMedCrossRef Barber SG, Smith JA, Hughes RC (1978) Melatonin as a tumour marker in a patient with pineal tumour. BMJ 2:328PubMedCrossRef
5.
Zurück zum Zitat Kennaway DJ, McCulloch G, Matthews CD et al (1979) Plasma melatonin, luteinizing hormone, follicle-stimulating hormone, prolactin, and corticoids in two patients with pinealoma. J Clin Endocrinol Metab 49:144–145PubMed Kennaway DJ, McCulloch G, Matthews CD et al (1979) Plasma melatonin, luteinizing hormone, follicle-stimulating hormone, prolactin, and corticoids in two patients with pinealoma. J Clin Endocrinol Metab 49:144–145PubMed
6.
Zurück zum Zitat Miles A, Tidmarsh SF, Philbrick D et al (1985) Diagnostic potential of melatonin analysis in pineal tumors. N Engl J Med 313:329–330PubMed Miles A, Tidmarsh SF, Philbrick D et al (1985) Diagnostic potential of melatonin analysis in pineal tumors. N Engl J Med 313:329–330PubMed
8.
Zurück zum Zitat Arendt J, Bojkowski C, Franey C et al (1985) Immunoassay of 6-hydroxymelatonin sulfate in human plasma and urine: abolition of the urinary 24-hour rhythm with atenolol. J Clin Endocrinol Metab 60:1166–1173PubMed Arendt J, Bojkowski C, Franey C et al (1985) Immunoassay of 6-hydroxymelatonin sulfate in human plasma and urine: abolition of the urinary 24-hour rhythm with atenolol. J Clin Endocrinol Metab 60:1166–1173PubMed
10.
Zurück zum Zitat Claustrat B, Chazot G, Brun J et al (1984) A chronobiological study of melatonin and cortisol secretion in depressed subjects: plasma melatonin, a biochemical marker in major depression. Biol Psychiatry 19:1215–1228PubMed Claustrat B, Chazot G, Brun J et al (1984) A chronobiological study of melatonin and cortisol secretion in depressed subjects: plasma melatonin, a biochemical marker in major depression. Biol Psychiatry 19:1215–1228PubMed
12.
Zurück zum Zitat Jouvet A, Nakazato Y, Scheithauer BW, Paulus W (2007) Papillary tumor of the pineal region. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) WHO classification of tumours of the central nervous system, vol 7. IARC, Lyon, pp 128–129 Jouvet A, Nakazato Y, Scheithauer BW, Paulus W (2007) Papillary tumor of the pineal region. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) WHO classification of tumours of the central nervous system, vol 7. IARC, Lyon, pp 128–129
13.
Zurück zum Zitat Bruce JN (2006) Pineal region masses: clinical features and management. In: Schmidek HH, Sweet WH (eds) Operative neurosurgical techniques, indications, methods and results, 5th edn. Saunders Elsevier, Philadelphia, pp 786–797 Bruce JN (2006) Pineal region masses: clinical features and management. In: Schmidek HH, Sweet WH (eds) Operative neurosurgical techniques, indications, methods and results, 5th edn. Saunders Elsevier, Philadelphia, pp 786–797
15.
Zurück zum Zitat Claustrat B, Brun J, Chazot G (2005) The basic physiology and pathophysiology of melatonin. Sleep Med Rev 9:11–24PubMedCrossRef Claustrat B, Brun J, Chazot G (2005) The basic physiology and pathophysiology of melatonin. Sleep Med Rev 9:11–24PubMedCrossRef
16.
Zurück zum Zitat Touitou Y, Fèvre-Montange M, Proust J et al (1985) Age- and sex-associated modification of plasma melatonin concentrations in man. Relationship to pathology, malignant or not, and autopsy findings. Acta Endocrinol (Copenh) 108:135–144 Touitou Y, Fèvre-Montange M, Proust J et al (1985) Age- and sex-associated modification of plasma melatonin concentrations in man. Relationship to pathology, malignant or not, and autopsy findings. Acta Endocrinol (Copenh) 108:135–144
18.
20.
Zurück zum Zitat Fèvre-Montange M, Hasselblatt M, Figarella-Branger D et al (2006) Prognosis and histopathologic features in papillary tumors of the pineal region: a retrospective multicenter study of 31 cases. J Neuropathol Exp Neurol 65:1004–1011PubMedCrossRef Fèvre-Montange M, Hasselblatt M, Figarella-Branger D et al (2006) Prognosis and histopathologic features in papillary tumors of the pineal region: a retrospective multicenter study of 31 cases. J Neuropathol Exp Neurol 65:1004–1011PubMedCrossRef
24.
Zurück zum Zitat Konovalov AN, Spallone A, Pitzkhelauri DI (1996) Meningioma of the pineal region: a surgical series of 10 cases. J Neurosurg 85:586–590PubMed Konovalov AN, Spallone A, Pitzkhelauri DI (1996) Meningioma of the pineal region: a surgical series of 10 cases. J Neurosurg 85:586–590PubMed
26.
Zurück zum Zitat Neuwelt EA, Lewy AJ (1983) Disappearance of plasma melatonin after removal of a neoplastic pineal gland. N Engl J Med 308:1132–1135PubMedCrossRef Neuwelt EA, Lewy AJ (1983) Disappearance of plasma melatonin after removal of a neoplastic pineal gland. N Engl J Med 308:1132–1135PubMedCrossRef
28.
Zurück zum Zitat Chazot G, Claustrat B, Broussolle E, Lapras C (1991) Headache and depression: recurrent symptoms in adult pinealectomized patients. In: Nappi G, Bono G, Sandrini G, Martignoni E, Micieli G (eds) Headache and depression. Raven Press, New York, pp 299–303 Chazot G, Claustrat B, Broussolle E, Lapras C (1991) Headache and depression: recurrent symptoms in adult pinealectomized patients. In: Nappi G, Bono G, Sandrini G, Martignoni E, Micieli G (eds) Headache and depression. Raven Press, New York, pp 299–303
Metadaten
Titel
Contribution of the daily melatonin profile to diagnosis of tumors of the pineal region
verfasst von
José Leston
Carmine Mottolese
Jacques Champier
Anne Jouvet
Jocelyne Brun
Marc Sindou
Guy Chazot
Bruno Claustrat
Michelle Fèvre-Montange
Publikationsdatum
01.07.2009
Verlag
Springer US
Erschienen in
Journal of Neuro-Oncology / Ausgabe 3/2009
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-008-9792-1

Weitere Artikel der Ausgabe 3/2009

Journal of Neuro-Oncology 3/2009 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.